Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Jiwon Jung, Heungsup Sung, Sung-Han Kim
Abstract
immunogenicity of a booster dose of BNT162b2 administered 7 to 9 months after the primary two-dose series suggest that a third dose could prolong protection and further increase the breadth of protection.
Topics & Concepts
ImmunogenicityBooster (rocketry)Coronavirus disease 2019 (COVID-19)Booster doseMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyImmunologyOutbreakInfectious disease (medical specialty)Internal medicineAntibodyVirusDiseaseTiterAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingInfection Control and Ventilation